A discovery by researchers at the University of British Columbia promises to improve care for patients with endometrial cancer, the most common gynecologic malignancy.
UBC AI & Health Network member Dr. Ali Bashashati and his team have developed a method using AI to identify a high-risk form of endometrial cancer that puts patients at much greater risk of recurrence and death, a discovery that could transform how this disease is diagnosed and treated.
“Endometrial cancer is a diverse disease, with some patients much more likely to see their cancer return than others,” said Dr. Jessica McAlpine, professor and Dr. Chew Wei Chair in Gynaecologic Oncology at UBC, and surgeon-scientist at BC Cancer and Vancouver General Hospital. “It’s so important that patients with high-risk disease are identified so we can intervene and hopefully prevent recurrence. This AI-based approach will help ensure no patient misses an opportunity for potentially lifesaving interventions.”
Comments are closed, but trackbacks and pingbacks are open.